Table I.
EGFR | ERCC1 | RRM1 | |||||||
---|---|---|---|---|---|---|---|---|---|
|
|
|
|||||||
Clinical features | Mutant (n) | Wild-type (n) | P-value | High (n) | Low (n) | P-value | High (n) | Low (n) | P-value |
Gender | <0.001 | 0.898 | 0.088 | ||||||
Male | 52 | 86 | 65 | 73 | 92 | 46 | |||
Female | 74 | 45 | 57 | 62 | 67 | 52 | |||
Age, years | 0.287 | 0.943 | 0.714 | ||||||
≥59 | 68 | 62 | 62 | 68 | 79 | 51 | |||
<59 | 58 | 69 | 60 | 67 | 80 | 47 | |||
Smoking history | <0.001 | 0.199 | 0.129 | ||||||
Yes | 34 | 65 | 52 | 47 | 67 | 32 | |||
No | 92 | 66 | 70 | 88 | 92 | 66 | |||
Tumor diameter, cm | 0.282 | 0.687 | 0.292 | ||||||
≥5 | 56 | 67 | 60 | 63 | 72 | 51 | |||
<5 | 70 | 64 | 62 | 72 | 87 | 47 | |||
Lymph node metastasis | 0.903 | 0.470 | 0.188 | ||||||
Yes | 51 | 54 | 47 | 58 | 70 | 35 | |||
No | 75 | 77 | 75 | 77 | 89 | 63 | |||
Clinical stage | 0.203 | 0.339 | 0.577 | ||||||
I | 50 | 42 | 40 | 52 | 59 | 33 | |||
II+III+IV | 76 | 89 | 82 | 83 | 100 | 65 |
EGFR, epidermal growth factor receptor; ERCC1, excision repair cross-complementing protein 1; RRM1, ribonucleotide reductase subunit M1.